Beriglobin

Beriglobin is a human normal immunoglobulin solution for intramuscular or subcutaneous use. It is designed to provide passive immunity and support the immune system.

Beriglobin is used to provide passive immunity in individuals who lack sufficient antibodies. It may be administered to prevent or treat infections in immunocompromised patients. The primary use of Beriglobin is to supplement the immune system, particularly in cases where the body's natural defenses are compromised.

Common effects of Beriglobin may include localized reactions at the injection site, such as redness, swelling, or pain. Some individuals may experience systemic effects like fever, chills, or headache. These effects are generally mild and transient.

Beriglobin should be used with caution in individuals with a history of severe allergic reactions to immunoglobulin products. It is important to follow the prescribed administration route, whether intramuscular or subcutaneous, to minimize the risk of adverse reactions. Always consult a healthcare provider before use.

Beriglobin may interact with certain medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking before starting Beriglobin. Additionally, avoid using Beriglobin concurrently with live virus vaccines, as it may reduce their effectiveness.